株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血漿分画製剤の世界市場

Plasma Fractionation

発行 Global Industry Analysts, Inc. 商品コード 908708
出版日 ページ情報 英文 145 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
血漿分画製剤の世界市場 Plasma Fractionation
出版日: 2019年10月01日 ページ情報: 英文 145 Pages
概要

当レポートでは、世界の血漿分画製剤市場について調査分析し、市場概要、主要企業、市場動向・促進要因、世界市場の見通し、地域別市場の分析、競合情勢について、体系的な情報を提供しています。

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
    • 世界の競合企業の市場シェア
  • 主要企業
  • 市場動向・促進要因
  • 世界市場の見通し

第3章 市場分析

  • 地域別市場の分析
    • 米国
    • カナダ
    • 日本
    • 中国
    • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • その他の欧州
    • アジア太平洋地域
    • その他の世界の地域

第4章 競合

  • BIO PRODUCTS LABORATORY
  • BIOTEST AG
  • CSL
  • CHINA BIOLOGIC PRODUCTS
  • GREEN CROSS CORPORATION
  • GRIFOLS SA
  • 日本血液製剤機構
  • KEDRION SPA
  • LFB SA
  • OCTAPHARMA AG
  • SANQUIN BLOOD SUPPLY
  • SHANGHAI RAAS BLOOD PRODUCTS
  • SHIRE PLC

第5章 関連調査

目次
Product Code: MCP14015

Plasma Fractionation market worldwide is projected to grow by US$11.4 Billion, driven by a compounded growth of 6.5%. Intravenous Immunoglobulins, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$10.9 Billion by the year 2025, Intravenous Immunoglobulins will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$522.6 Million to the region's size and clout in the next 5 to 6 years. Over US$532.1 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Intravenous Immunoglobulins will reach a market size of US$1 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.2% over the next couple of years and add approximately US$2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Bio Products Laboratory Ltd.; Biotest AG; China Biologic Products, Inc.; CSL Limited; Green Cross Corporation; Grifols SA; Japan Blood Products Organization; Kedrion SpA; LFB SA; Octapharma AG; Sanquin; Shanghai RAAS Blood Products Co., Ltd.; Shire PLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Plasma Fractionation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Plasma Fractionation Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Plasma Fractionation Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Plasma Fractionation Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Intravenous Immunoglobulins (Product) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Intravenous Immunoglobulins (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Intravenous Immunoglobulins (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Coagulation Factor Concentrates (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Coagulation Factor Concentrates (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Coagulation Factor Concentrates (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Albumin (Product) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Albumin (Product) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Albumin (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Protease Inhibitors (Product) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Protease Inhibitors (Product) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Protease Inhibitors (Product) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Other Products (Product) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Other Products (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Other Products (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Hospitals & Clinics (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025
  • TABLE 20: Hospitals & Clinics (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017
  • TABLE 21: Hospitals & Clinics (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
  • TABLE 22: Clinical Research Laboratories (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
  • TABLE 23: Clinical Research Laboratories (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 24: Clinical Research Laboratories (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Academic Institutes (End-Use) Worldwide Sales in US$ Million by Region/Country: 2018-2025
  • TABLE 26: Academic Institutes (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
  • TABLE 27: Academic Institutes (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Plasma Fractionation Market Share (in %) by Company: 2019 & 2025
    • TABLE 28: United States Plasma Fractionation Market Estimates and Projections in US$ Million by Product: 2018 to 2025
    • TABLE 29: Plasma Fractionation Market in the United States by Product: A Historic Review in US$ Million for 2009-2017
    • TABLE 30: United States Plasma Fractionation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 31: United States Plasma Fractionation Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
    • TABLE 32: Plasma Fractionation Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017
    • TABLE 33: Plasma Fractionation Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 34: Canadian Plasma Fractionation Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 35: Canadian Plasma Fractionation Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 36: Plasma Fractionation Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
    • TABLE 37: Canadian Plasma Fractionation Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
    • TABLE 38: Plasma Fractionation Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
    • TABLE 39: Canadian Plasma Fractionation Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
  • JAPAN
    • TABLE 40: Japanese Market for Plasma Fractionation: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 41: Plasma Fractionation Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 42: Japanese Plasma Fractionation Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 43: Japanese Demand Estimates and Forecasts for Plasma Fractionation in US$ Million by End-Use: 2018 to 2025
    • TABLE 44: Japanese Plasma Fractionation Market in US$ Million by End-Use: 2009-2017
    • TABLE 45: Plasma Fractionation Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 46: Chinese Plasma Fractionation Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 47: Plasma Fractionation Historic Market Analysis in China in US$ Million by Product: 2009-2017
    • TABLE 48: Chinese Plasma Fractionation Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 49: Chinese Demand for Plasma Fractionation in US$ Million by End-Use: 2018 to 2025
    • TABLE 50: Plasma Fractionation Market Review in China in US$ Million by End-Use: 2009-2017
    • TABLE 51: Chinese Plasma Fractionation Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
  • EUROPE
    • Market Facts & Figures
    • European Plasma Fractionation Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 52: European Plasma Fractionation Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 53: Plasma Fractionation Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 54: European Plasma Fractionation Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 55: European Plasma Fractionation Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 56: Plasma Fractionation Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 57: European Plasma Fractionation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 58: European Plasma Fractionation Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
    • TABLE 59: Plasma Fractionation Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
    • TABLE 60: European Plasma Fractionation Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 61: Plasma Fractionation Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 62: French Plasma Fractionation Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 63: French Plasma Fractionation Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 64: Plasma Fractionation Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025
    • TABLE 65: French Plasma Fractionation Historic Market Review in US$ Million by End-Use: 2009-2017
    • TABLE 66: French Plasma Fractionation Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
  • GERMANY
    • TABLE 67: Plasma Fractionation Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 68: German Plasma Fractionation Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 69: German Plasma Fractionation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 70: Plasma Fractionation Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
    • TABLE 71: German Plasma Fractionation Market in Retrospect in US$ Million by End-Use: 2009-2017
    • TABLE 72: Plasma Fractionation Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 73: Italian Plasma Fractionation Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 74: Plasma Fractionation Historic Market Analysis in Italy in US$ Million by Product: 2009-2017
    • TABLE 75: Italian Plasma Fractionation Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 76: Italian Demand for Plasma Fractionation in US$ Million by End-Use: 2018 to 2025
    • TABLE 77: Plasma Fractionation Market Review in Italy in US$ Million by End-Use: 2009-2017
    • TABLE 78: Italian Plasma Fractionation Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
  • UNITED KINGDOM
    • TABLE 79: United Kingdom Market for Plasma Fractionation: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 80: Plasma Fractionation Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 81: United Kingdom Plasma Fractionation Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 82: United Kingdom Demand Estimates and Forecasts for Plasma Fractionation in US$ Million by End-Use: 2018 to 2025
    • TABLE 83: United Kingdom Plasma Fractionation Market in US$ Million by End-Use: 2009-2017
    • TABLE 84: Plasma Fractionation Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 85: Rest of Europe Plasma Fractionation Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 86: Plasma Fractionation Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 87: Rest of Europe Plasma Fractionation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 88: Rest of Europe Plasma Fractionation Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
    • TABLE 89: Plasma Fractionation Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
    • TABLE 90: Rest of Europe Plasma Fractionation Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 91: Plasma Fractionation Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 92: Asia-Pacific Plasma Fractionation Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 93: Asia-Pacific Plasma Fractionation Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 94: Plasma Fractionation Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
    • TABLE 95: Asia-Pacific Plasma Fractionation Historic Market Review in US$ Million by End-Use: 2009-2017
    • TABLE 96: Asia-Pacific Plasma Fractionation Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
  • REST OF WORLD
    • TABLE 97: Rest of World Plasma Fractionation Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 98: Rest of World Plasma Fractionation Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 99: Plasma Fractionation Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
    • TABLE 100: Rest of World Plasma Fractionation Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
    • TABLE 101: Plasma Fractionation Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
    • TABLE 102: Rest of World Plasma Fractionation Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

  • BIO PRODUCTS LABORATORY
  • BIOTEST AG
  • CSL
  • CHINA BIOLOGIC PRODUCTS
  • GREEN CROSS CORPORATION
  • GRIFOLS SA
  • JAPAN BLOOD PRODUCTS ORGANIZATION
  • KEDRION SPA
  • LFB SA
  • OCTAPHARMA AG
  • SANQUIN BLOOD SUPPLY
  • SHANGHAI RAAS BLOOD PRODUCTS
  • SHIRE PLC

V. CURATED RESEARCH

Back to Top